Crosstalk between PARP-1 and NF-κB modulates the promotion of skin neoplasia
- 12 April 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (31), 5275-5283
- https://doi.org/10.1038/sj.onc.1207696
Abstract
Poly (ADP-ribose) polymerase-1 (PARP-1)-deficient mice are protected against septic shock, type I diabetes, stroke and inflammation. It is now accepted that inflammation and related events, such as activation of NF-B, are key components in the initiation and progression of epithelial cancer and in particular in the neoplastic transformation of keratinocytes and skin carcinogenesis. Here, we report that PARP-1-deficient mice display a strikingly reduced susceptibility to skin carcinogenesis. In parp-1-/- mice, development of papilloma-like premalignant lesions induced with DMBA and TPA, is strongly delayed and the final number of tumor-bearing mice and total tumor number were significantly reduced. In addition, epidermis of parp-1-/- mice did not show increased proliferation rates after treatment with carcinogen. Deregulated NF-B is a hallmark for tumorigenesis together with the concomitant release of early inflammatory mediators. In the absence of PARP-1, NF-B activation and induction B-target genes did not take place during the promotion of tumor development. These results suggest that PARP-1 abolition impairs the promotion of skin carcinogenesis interfering with the activation of NF-B and might have an important implication in targeting PARP-1 as a new antineoplastic therapeutic approach.This publication has 37 references indexed in Scilit:
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancerCancer Letters, 2002
- Expression of serum amyloid A genes in mouse brain: unprecedented response to inflammatory mediatorsThe FASEB Journal, 2001
- Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase–deficient mice and primary cells despite increased chromosomal instabilityThe Journal of cell biology, 2001
- Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoterOncogene, 2000
- The transcription factor NF-κB: control of oncogenesis and cancer therapy resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2000
- Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesisOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994